Venn Life Sciences Share Discussion Threads

[jpuff] 28/2/2017 19:10

Looking at the chart its at a three year low. Is there any point throwing good money after bad given the chart could look the same or worse! In say five to ten years? More of a reckless gamble than a supposed investment it seems to me and I certainly would be recommending folk stay well clear of this POS.

[tradermick1] 28/2/2017 19:02

There's the reversal, mind you I missed the 15.5p offer but some got in at a great price and finished already 10% up

[pentangle] 28/2/2017 18:42

A one day reversal is a pretty bullish sign so here's hoping!

[cumnor] 28/2/2017 16:29

Bought back in again today. Bit of a gamble.

[b1ggles] 28/2/2017 16:16

What an odd day's trading!

[rivaldo] 28/2/2017 15:51

Nice positive turnaround :o))

Thx to harryverdici and chadders for the posts re Integumen. It's definitely going forward then, just a question of time and success in completing the fundraising.

[shanklin] 28/2/2017 13:44

Last year the results were released on 10-May albeit there was a "Year end update" on 24-Mar and a "Trading Update" on 08-Jan.

The title within the RNS on 08-Jan was "Year End Update". This update was sufficiently vague that I find it difficult to see why they could not have updated the market far more promptly this time round.

[chadders] 28/2/2017 13:43

Rivaldo, I'm sure and I note Harry has kindly posted a link to crowd of angels. I picked it up somewhere else.

News is the same though 23.5% is on offer for £2.1 million pre float valuing it at £9 million - if they get it away of course. £800k already secured.

[glasshalfull] 28/2/2017 13:12

Like rivaldo, I'd nothing further to add to the thread. Wouldn't consider myself a cheer leader, although I'm still invested here & indeed topped up my holding modestly this morning.

Following the excellent meeting updates posted on here end Sept, there's been little news since contract win RNS in November, with exception of a number of posters talking about the share price fall and bemoaning the lack of an update.

VENN will be releasing an update in March so we'll have more to talk about then.

Kind regards,
GHF

[yump] 28/2/2017 12:14

In the absense of announcements, you can probably count recent buyers on one hand. If nobody is buying, the only thing left is a share price plummet.

I reckon there will have been some expenses in the Integumen sale, which will turn out to have prevented that PBT 'promise' from coming true. There's always someone making money out of these arrangements and its never the businesses themselves.

Optimistically, taking 'one-offs' out, it should be apparent whether the core is showing anything worthwhile as growth. If it is, there should be a quick rebound.

[rivaldo] 28/2/2017 11:50

No point in posting very often if there's not much of use to say rather than going on about "if's" and "might be's".

Chadders, are you definitive about the Integumen fundraising being "on the go? Although I appreciate these things can take an inordinate length of time, this is taking rather too long!

Volumes have been small AFAICS? Looks to me like small investors getting bored/stop losses being hit more than anything else. There haven't been any large contract wins for 3 months, but the outlook for the business seemed promising enough.

The Chairman bought £50,000 of shares at 21.67p back in November. Let's hope he was the prescient one, and not the recent sellers.

[pentangle] 28/2/2017 11:31

It's hard to read a crashing share price and a deafening silence from the BOD as anything but the portent of bad news. At best it's small sellers hitting their stop losses rather than acting on any information. Certainly those who sold out at 20 are looking rather clever which, tbh, I did not think at the time as I expected it to bounce off support.

[tradermick1] 28/2/2017 09:42

Still think they are shaking this a bit, 50k buy at open delay it one our and a few sellers give the mm it back.

Currently 16.17-16.4p spread and I can sell size no problem so looking for a intraday reversal at some point

[tradermick1] 27/2/2017 22:54

I think if there is no bad Rns tomorrow the shares will bounce, the mm's seem to have looked for a support level which seems to be 16.5-17p which includes a lot of buys showing as sales.

[chadders] 27/2/2017 16:25

Added at 16.58p. No brainer for me, Integumen fund raising on the go.

[tradermick1] 27/2/2017 16:25

Maybe nothing wrong just looking for a support level, check Feb trades it's been 90% sales so people getting bored selling up, support sub 17p

[tradermick1] 27/2/2017 16:23

free money sell at 16.65p buy at 16.58p currently

[investordave] 27/2/2017 16:14

And it would seem that a lot of those selling out from 28p were in the know. A disgraceful business.

[shanklin] 27/2/2017 16:11

Well I'm belatedly out. Anything could be going on here.

[cocker] 27/2/2017 14:52

Agree Yump. The Innovenn sale on the outside looks to be of some value to Venn. Dig deeper & if ipo is under subscribed could well prove to be an achilles heel. All said & done I know I keep barking on about it, but a reassurance of year end is needed.

[yump] 27/2/2017 13:50

Last year:

Trading update: 8th. Jan
Year end update: 24th. March
Results: 10th. May

So for all we know it could simply be difficult to issue a meaningful trading update, although the sale of Innovenn shouldn't affect the performance of the rest of the business; they could update on that as far as possible, even if likely p&l is difficult to get at.

Worst case, they don't want to update, because things didn't go as expected with the core business to Dec. 16.

They have no wiggle-room imo.

To issue the statement in June, that they were on track and very confident in meeting full year forecasts and a profit before tax and then to find out that they don't, is going to imply that either they have no idea what they are doing, or they do, but are at best being economical or evasive with the truth.

If the sale of Innovenn is going to hit their own forecast PBT, then they should have said so.

Perhaps they made the statement and nothing has changed. That would be the best case, but looks unlikely to me.

The more I look at it, the more the 'sale' of Innovenn isn't really a sale of anything of worth to Venn and could easily give zero return on all the work done within that research area.

[shrout] 27/2/2017 13:35

Thankfully I only have a handful of shares left in this awful dog. As soon as an announcement is made I'm going to sell up, whether the news is good, bad or indifferent, and never buy back. I've lost all faith in this company.